Download PDFPDF

2022-RA-1206-ESGO Selection of preexisting BRCA1/2-proficient tumor cells in BRCA1/2-driven tubo-ovarian carcinomas treated by neoadjuvant chemotherapy
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address